0001628280-24-000294.txt : 20240103 0001628280-24-000294.hdr.sgml : 20240103 20240103181825 ACCESSION NUMBER: 0001628280-24-000294 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231229 FILED AS OF DATE: 20240103 DATE AS OF CHANGE: 20240103 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hasnain Faheem CENTRAL INDEX KEY: 0001352620 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35921 FILM NUMBER: 24508772 MAIL ADDRESS: STREET 1: 14 CAMBRIDGE CENTER CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Mirati Therapeutics, Inc. CENTRAL INDEX KEY: 0001576263 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 462693615 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3545 CRAY COURT CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-332-3410 MAIL ADDRESS: STREET 1: 3545 CRAY COURT CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 wk-form4_1704323893.xml FORM 4 X0508 4 2023-12-29 0 0001576263 Mirati Therapeutics, Inc. MRTX 0001352620 Hasnain Faheem C/O MIRATI THERAPEUTICS, INC 3545 CRAY COURT SAN DIEGO CA 92121 1 0 0 0 0 Common Stock 2023-12-29 4 A 0 9702 58.75 A 24752 D Grant of Restricted Stock Units (RSUs). Shares will vest 100% on the anniversary of the grant date. /s/ John Moriarty, Attorney-in-Fact 2024-01-03